ScienceDex / Researcher record
Benjamin Elison Gewurz
- Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)
- Wistar Institute (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #3,472
- Program Leader
- R01 Holder
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,573,961 | 7 | #3,444 |
| 2025 | $2,966,200 | 7 | #3,472 |
| 2026 | $4,816,038 | 6 | #2,998 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20247 records
- FY2025 · selected7 records
- FY20266 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9613146Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-3965-3418Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pathology
FY2025 award records by amount
NIH award records listing Benjamin Elison Gewurz as a PI. Multi-PI records show the full award amount for context.
- 5U01CA275301-04U01Co-investigatorB cell determinants of EBV latencyWeill Cornell Medicine · Pathology (NIH department code)$827.2Kaward amount
- 2R01CA228700-06A1R01Contact PIEpstein-Barr virus LMP1 mediated oncogenicityBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$616Kaward amount
- 5R01DE033907-02R01Contact PIEpstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network RemodelingBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$508.5Kaward amount
- 5R01AI164709-05R01Contact PIRegulation of the Epstein-Barr Virus Lytic SwitchBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$505.7Kaward amount
- 5R21AI181873-02R21Contact PISystematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell LysisBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$268.5Kaward amount
- 5P01CA269043-03P01Contact PITargeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers$210.1Kaward amount
- 3U01CA275301-03S1U01Co-investigatorB cell determinants of EBV latency (supplement)Weill Cornell Medicine · Pathology (NIH department code)$30.1Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Benjamin Elison Gewurz as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBrigham and Women's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3444
- 2024Entered Top 25% NationallyRanked #3444
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 3 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$10M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Benjamin Elison Gewurz.